16 days left
Estimated value£1,512,963
Deadline16 days left6 Nov 2026, 23:59
Competition00 participants
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
Contract type
—
Deadline
6 Nov 2026, 23:59
CPV codes
33600000 - Pharmaceutical products
Status
Planning
Notice type
UK2Preliminary market engagement notice
Estimated value
£1,512,963
Publication date
28 Sept 2026, 10:47

Overview

Supply of Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK.

Procurement Act 2023

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). This contract is for Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK. There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Rachelle Elvin ([email protected]).

Contracting authorities1

Lots1

Documentation0

Documents have not been synced yet. Last checked 21 Oct 2026, 22:21.

Award criteria0

No procedure-level award criteria recorded.

Participants0

No participants recorded for this notice.